Oligodendrogenesis is differentially regulated in gray and white matter of jimpy mice

Journal of Neuroscience Research

Volumn 70, Issue 5, 2002, Pages 645-654

  Baracskay, Karen L ^a,b   Duchala, Cynthia S ^b   Miller, Robert H ^a   Macklin, Wendy B ^a,b   Trapp, Bruce D ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; Leukodystrophies; Msd; NG2 cells; Oligodendrocyte development; Oligodendrocyte progenitor cells; Proteolipid protein

Indexed keywords

PROTEOLIPID PROTEIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DEATH; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; GENE MUTATION; GRAY MATTER; MALE; MOUSE; MOUSE STRAIN; MYELINATION; NONHUMAN; OLIGODENDROGLIA; OPTIC NERVE; PRIORITY JOURNAL; STEM CELL; WHITE MATTER; WILD TYPE;

ANIMALS; CELL DEATH; CELL DIVISION; CEREBRAL CORTEX; CORPUS CALLOSUM; MALE; MICE; MICE, INBRED STRAINS; MICE, JIMPY; MYELIN PROTEOLIPID PROTEIN; MYELIN SHEATH; OLIGODENDROGLIA; STEM CELLS;

EID: 0036892754     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10418     Document Type: Article

References (57)

1. Barres BA, Hart IK, Coles HSR., Burne JF, Voyvodic JT, Richardson WD, Raff MC. 1992. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70:31-46.
2. Bence NF, Sampat RM, Kopito RR. 2001. Impairment of the ubiquitinproteasome system by protein aggregation. Science 292:1552-1555.
3. Bergles DE, Roberts JD, Somogyi P, Jahr CE. 2000. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature 405:187-191.
4. Bhat RV, Axt KJ, Fosnaugh JS, Smith KJ, Johnson KA, Hill DE, Kinzler KW, Baraban JM. 1996. Expression of the APC tumor suppressor protein in oligodendroglia. Glia 17:169-174.
5. Boison D, Stoffel W. 1994. Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice. Proc Natl Acad Sci USA 91:11709-11713.
6. Deschenes SM, Walcott JL, Wexler TL, Scherer SS, Fischbeck KH. 1997. Altered trafficking of mutant connexin32. J Neurosci 17:9077-9084.
7. Gencic S, Hudson LD. 1990. Conservative amino acid substitution in the myelin proteolipid protein of jimpy msd mice. J Neurosci 10:117-124.
8. Ghandour MS, Skoff RP. 1988. Expression of galactocerebroside in developing normal and jimpy oligodendrocytes in situ. J Neurocytol 17:485-498.
9. Gow A, Friedrich VL, Jr, Lazzarini RA. 1994. Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport. J Neurosci Res 37:574-583.
10. Gow A, Southwood CM, Lazzarini RA. 1998. Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. J Cell Biol 140:925-934.
11. Hall A, Giese NA, Richardson WD. 1996. Spinal cord oligodendrocytes develop from ventrally derived progenitor cells that express PDGF alphareceptors. Development 122:4085-4094.
12. He W, Ingraham C, Rising L, Goderie S, Temple S. 2001. Multipotent stem cells from the mouse basal forebrain contribute GABAergic neurons and oligodendrocytes to the cerebral cortex during embryogenesis. J Neurosci 21:8854-8862.
13. Hudson LD, Berndt J, Puckett C, Kozak CA, Lazzarini RA. 1987. Aberrant splicing of proteolipid protein mRNA in the dysmyelinating jimpy mouse. Proc Natl Acad Sci USA 84:1454-1458.
14. Huxley C, Passage E, Robertson AM, Youl B, Huston S, Manson A, Saberan-Djoniedi D, Figarella-Branger D, Pellissier JF, Thomas PK, Fontes M. 1998. Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum Mol Genet 7:449-458.
15. Johnston JA, Ward CL, Kopito RR. 1998. Aggresomes: A cellular response to misfolded proteins. J Cell Biol 143:1883-1898.
16. Kagawa T, Ikenaka K, Inoue Y, Kuriyama S, Tsujii T, Nakao J, Nakajima K, Aruga J, Okano H, Mikoshiba K. 1994. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 13:427-442.
17. Klugmann M, Schwab MH, Puhlhofer A, Schneider A, Zimmermann F, Griffiths IR, Nave KA. 1997. Assembly of CNS myelin in the absence of proteolipid protein. Neuron 18:59-70.
18. Knapp PE. 1996. Proteolipid protein: Is it more than just a structural component of myelin? Dev Neurosci 18:297-308.
19. Knapp PE, Skoff RP, Redstone DW. 1986. Oligodendroglial cell death in jimpy mice: An explanation for the myelin deficit. J Neurosci 6:2813-2822.
20. Koeppen AH, Barron KD, Csiza CK, Greenfield EA. 1988. Comparative immunocytochemistry of Pelizaeus-Merzbacher disease, the jimpy mouse, and the myelin-deficient rat. J Neurol Sci 84:315-327.
21. Lachapelle F, Lapie P, Gansmuller A, Villarroya H, Gumpel M. 1990. Patchy myelination pattern in the jimpy mouse brain: Immunohistochemical study. Glia 3:375-384.
22. Levine JM, Card JP. 1987. Light and electron microscopic localization of a cell surface antigen (NG2) in the rat cerebellum: Association with smooth protoplasmic astrocytes. J Neurosci 7:2711-2720.
23. Levine JM, Stincone F, Lee YS. 1993. Development and differentiation of glial precursor cells in the rat cerebellum. Glia 7:307-321.
24. Macklin WB, Gardinier MV, King KD, Kampf K. 1987. An AG-GG transition at a splice site in the myelin PLP gene in jimpy mice results in the removal of an exon. FEBS Lett 223:417-421.
25. Magyar JP, Martini R, Ruelicke T, Aguzzi A, Adlkofer K, Dembic Z, Zielasek J, Toyka KV, Suter U. 1996. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci 16:5351-5360.
26. Mallon BS, Shick HE, Kidd GJ, Macklin WB. 2002. Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J Neurosci 22;876-885.
27. Manganas LN, Akhtar S, Antonucci DE, Campomanes CR, Dolly JO, Trimmer JS. 2001. Episodic ataxia type-1 mutations in the Kv1.1 potassium channel display distinct folding and intracellular trafficking properties. J Biol Chem 276:49427-49434.
28. Martin PE, Mambetisaeva ET, Archer DA, George CH, Evans WH. 2000. Analysis of gap junction assembly using mutated connexins detected in Charcot-Marie-Tooth X-linked disease. J Neurochem 74:711-720.
29. Nakao J, Yamada M, Kagawa T, Kim SU, Miyao Y, Shimizu K, Mikoshiba K, Ikenaka K. 1995. Expression of proteolipid protein gene is directly associated with secretion of a factor influencing oligodendrocyte development. J Neurochem 64:2396-2403.
30. Nave K-A, Bloom F, Milner RJ. 1987. A single nucleotide difference in the gene for myelin proteolipid protein defines the jimpy mutation in mouse. J Neurochem 49:1873-1877.
31. Nishiyama A, Lin XH, Giese N, Heldin CH, Stallcup WB. 1996. Colocalization of NG2 proteoglycan and PDGFα receptor on 02A progenitor cells in the developing rat brain. J Neurosci Res 43:299-314.
32. Notterpek L, Ryan MC, Tobler AR, Shooter EM. 1999. PMP22 accumulation in aggresomes: Implications for CMT1A pathology. Neurobiol Dis 6:450-460.
33. Peterson JW, Bo L, Mork S, Chang A, Trapp BD. 2001. Transected neurites, apoptotic neurons and reduced inflammation in cortical MS lesions. Ann Neurol 50:389-400.
34. Privat A, Valat J, Lachapelle F, Baumann N, Fulcrand J. 1982. Radioautographic evidence for the protracted proliferation of glial cells in the central nervous system of jimpy mice. Brain Res Dev Brain Res 2:411-416.
35. Readhead C, Schneider A, Griffiths I, Nave K-A. 1994. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron 12:583-595.
36. Reynolds R, Hardy R. 1997. Oligodendroglial progenitors labeled with the O4 antibody persist in the adult rat cerebral cortex in vivo. J Neurosci Res 47:455-470.
37. Robinson S, Tani M, Strieter RM, Ransohoff RM, Miller RH. 1998. The chemokine growth-regulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation. J Neurosci 18:10457-10463.
38. Sanders CR, Ismail-Beigi F, McEnery MW. 2001. Mutations of peripheral myelin protein 22 result in defective trafficking through mechanisms which may be common to diseases involving tetraspan membrane proteins. Biochemistry 40:9453-9459.
39. Sereda M, Griffiths I, Pühlhofer A, Stewart H, Rossner MJ, Zimmermann F, Magyar JP, Schnieder A, Hund E, Meinck H-M, Suter U, Nave K-A. 1996. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 16:1049-1060.
40. Sidman RL, Dickie MM, Appel SH. 1964. Mutant mice (quaking and jumpy) with deficient myelination in the central nervous system. Science 144:309-311.
41. Skoff RP. 1976. Myelin deficit in the Jimpy mouse may be due to cellular abnormalities in astroglia. Nature 264:560-562.
42. Skoff RP. 1982. Increased proliferation of oligodendrocytes in the hypomyelinated mouse mutant-jimpy. Brain Res 248:19-31.
43. Small RK, Riddle P, Noble M. 1987. Evidence for migration of oligodendrocyte-type-2 astrocyte progenitor cells into the developing rat optic nerve. Nature 328:155-157.
44. Spassky N, Goujet-Zalc C, Parmantier E, Olivier C, Martinez S, Ivanova A, Ikenaka K, Macklin W, Cerruti I, Zalc B, Thomas JL. 1998. Multiple restricted origin of oligodendrocytes. J Neurosci 18:8331-8343.
45. Srinivasan A, Roth KA, Sayers RO, Shindler KS, Wong AM, Fritz LC, Tomaselli KJ. 1998. In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system. Cell Death Differ 5:1004-1016.
46. Stallcup WB, Beasley L. 1987. Bipotential glial precursor cells of the optic nerve express the NG2 proteoglycan. J Neurosci 7:2737-2744.
47. Terada N, Baracskay K, Melrose S, Brophy PJ, Trapp BD. 2001, CD9 expression starts from late stage of oligodendrocyte progenitor cells. Soc Neurosci Abstr 27:1238.
48. Trapp BD, Nishiyama A, Cheng D, Macklin W. 1997. Differentiation and death of premyelinating oligodendrocytes in developing rodent brain. J Cell Biol 137:459-468.
49. Ueda H, Levine JM, Miller RH, Trapp BD. 1999. Rat optic nerve oligodendrocytes develop in the absence of viable retinal ganglion cell axons. J Cell Biol 146:1365-1374.
50. Vela Hernandez JM, Dahnau I, Gonzalez B, Castellano B. 1997. Abnormal expression of the proliferating cell nuclear antigen (PCNA) in the spinal cord of the hypomyelinated Jimpy mutant mice. Brain Res 747:130-139.
51. Vela JM, Dalmau I, Acarin L, Gonzalez B, Castellano B. 1995. Microglial cell reaction in the gray and white matter in spinal cords fromjimpy mice: An enzyme histochemical study at the light and electron microscope level. Brain Res 694:287-298.
52. Vela JM, Dalmau I, Gonzalez B, Castellano B. 1996. The microglial reaction in spinal cords of jimpy mice is related to apoptotic oligodendrocytes. Brain Res 712:134-142.
53. Vermeesch MK, Knapp PE, Skoff RP, Studzinski DM, Benjamins JA. 1990. Death of individual oligodendrocytes in jimpy brain precedes expression of proteolipid protein. Dev Neurosci 12:303-315.
54. Wu Q, Miller RH, Ransohoff RM, Robinson S, Bu J, Nishiyama A. 2000. Elevated levels of the chemokine GRO-1 correlate with elevated oligodendrocyte progenitor proliferation in the jimpy mutant. J Neurosci 20:2609-2617.
55. Yamada M, Ivanova A, Yamaguchi Y, Lees MB, Ikenaka K. 1999. Proteolipid protein gene product can be secreted and exhibit biological activity during early development. J Neurosci 19:2143-2151.
56. Yamada M, Jung M, Tetsushi K, Ivanova A, Nave KA, Ikenaka K. 2001. Mutant Plp/DM20 cannot be processed to secrete PLP-related oligodendrocyte differentiation/survival factor. Neurochem Res 26:639-645.
57. Yang X, Skoff RP. 1997. Proteolipid protein regulates the survival and differentiation of oligodendrocytes. J Neurosci 17:2056-2070.